Summit Therapeutics Inc. (SMMT)
↓ Download CSV- Sector Manufacturing
- Fiscal year ends Dec 31
Key ratios (FY2025)
-163.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $705.0K | $1.81M | $860.0K | $57.09M | — |
| Operating Income | — | -$226.00M | -$609.65M | -$72.09M | -$86.19M | -$53.19M | $5.39M | — |
| Net Income | -$1.08B | -$221.31M | -$614.93M | -$78.78M | -$88.60M | -$52.70M | $10.87M | — |
| EPS (Diluted) | $-1.44 | $-0.31 | $-0.99 | $-0.41 | $-0.67 | $-0.76 | $0.63 | — |
| Total Assets | $751.18M | $435.56M | $202.95M | $664.17M | $113.37M | $102.50M | $96.25M | — |
| Total Liabilities | $92.32M | $46.81M | $125.26M | $537.51M | $30.09M | $23.05M | $17.39M | — |
| Shareholders' Equity | $658.86M | $388.75M | $77.69M | $126.65M | $83.28M | $79.45M | $78.86M | -$3.59M |
| Cash & Equivalents | $225.27M | $104.86M | $71.42M | $348.61M | $71.79M | $66.42M | $63.84M | — |
| Operating Cash Flow | -$322.93M | -$142.11M | -$76.76M | -$41.58M | -$72.59M | -$48.11M | -$35.11M | — |
| Capital Expenditures | $657.0K | $139.0K | $128.0K | $624.0K | $306.0K | $421.0K | $157.0K | — |
| Shares Outstanding | 775.37M | 737.63M | 701.66M | 211.09M | 98.04M | 82.58M | 67.18M | — |